If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 1 - 8 of 8
Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD)
Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD)
Protocol No
GI-YARUR-SPARC
Categories
Assessment of Cardiovascular Risk in Inflammatory Bowel Disease Patients
Cardiovascular Risk in IBD
Protocol No
GI-IIT-SINH-CV-IN-IBD
Categories
LOGIC: Longitudinal Cohort of Older Individuals with Crohn's and Colitis - Differentiating the Fit from the Frail
Longitudinal Cohort of Crohn's and Colitis
Protocol No
GI-CCF-LOGIC
Categories
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial to Evaluate the Safety and Efficacy of TU-100 as an Adjunct to an Enhanced Recovery after Surgery (ERAS) Protocol in Subjects Undergoing Bowel Resection
Tsumura TU-100 as an Adjunct to an ERAS Protocol in Bowel Resections
Protocol No
SURG-TSUMURA-TU-100
Categories
Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Crohn's Disease: The OPTIMIZE Trial
Proactive Infliximab Optimization Using a PK Dashboard Versus SOC in Patients With Crohn's Disease: The OPTIMIZE Trial
Protocol No
GI-BIDMC-OPTIMIZE
Categories
A Multicenter, Randomized, Double-Blind, Parallel-Group Study To Assess The Efficacy And Safety Of Oral Etrasimod as Induction And Maintenance Therapy For Moderately To Severely Active Crohns Disease
A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease (CULTIVATE)
Protocol No
GI-ARENA-CULTIVATE-CD
Categories
An Open-Label Extension Study of Etrasimod in Subjects with Moderately to Severely Active Ulcerative Colitis
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis (ELEVATE UC OLE)
Protocol No
GI-ARENA-ELEVATE-UC-OLE
Categories
A Phase 2b Randomized, Double-blind, Active-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Induction and Maintenance Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely A
Guselkumab and Golimumab in Moderately to Severely Active Ulcerative Colitis
Protocol No
GI-JANSSEN-DUET-UC
Categories